Nanotechnology Advances in Diagnostics, Drug Delivery, and Regenerative Medicine

The Nano-Micro Interface: Bridging the Micro and Nano Worlds: Second Edition

Volumn 2-2, Issue , 2015, Pages 311-340

  Kiparissides, Costas ^a   Kammona, Olga ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

Author keywords

Cell therapy; Drug delivery systems (DDSs); Molecular diagnostics; Nanotechnology; Personalized medical therapies; Regenerative medicine (RM); Tissue engineering (TE)

Indexed keywords

BIOCHIPS; CELL ENGINEERING; CONTROLLED DRUG DELIVERY; MEDICAL NANOTECHNOLOGY; NANOSENSORS; NANOTECHNOLOGY; REGENERATIVE MEDICINE; TARGETED DRUG DELIVERY; TISSUE; TISSUE ENGINEERING;

CELL THERAPY; DRUG DELIVERY SYSTEM; MEDICAL THERAPY; MINIMALLY INVASIVE; MOLECULAR DIAGNOSTICS; NANOSENSOR DEVICES; PROTEIN MICROARRAY; SINGLE MOLECULE LEVEL;

DIAGNOSIS;

EID: 85018200189     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527679195.ch16     Document Type: Chapter

References (84)

1. Nanomedicine (2006) Nanotechnology for Health, European Technology Platform, Strategic Research Agenda for Nanomedicine, November 2006, http://www.etpnanomedicine.eu/public/press-documents/publications/etpn-publications (accessed 14 January 2014).
2. Etheridge, M.L., Campbell, S.A., Erdman, A.G., Haynes, C.L., Wolf, S.M., and McCullough, J. (2013) The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomed. Nanotechnol., 9, 1-14.
3. Nanomedicine (2009) Roadmaps in Nanomedicine towards 2020, Joint European Commission/ETP Nanomedicine Expert Report 2009, http://www.etpnanomedicine.eu/public/press-documents/publications/etpn-publications (accessed 14 January 2014).
4. Ahmed, N., Fessi, H., and Elaissari, A. (2012) Theranostic applications of nanoparticles in cancer. Drug Discov. Today, 17 (17/18), 928-934.
5. Chi, X., Huang, D., Zhao, Z., Zhou, Z., Yin, Z., and Gao, J. (2012) Nanoprobes for in vitro diagnostics of cancer and infectious diseases. Biomaterials, 33, 189-206.
6. Hu, Y., Fine, D.H., Tasciotti, E., Bouamrani, A., and Ferrari, M. (2011) Nanodevices in diagnostics. WIREs Nanomed. Nanobiotechnol., 3, 11-32.
7. Probst, J., Dembski, S., Milde, M., and Rupp, S. (2012) Luminescent nanoparticles and their use for in vitro and in vivo diagnostics. Expert Rev. Mol. Diagn., 12 (1), 49-64.
8. Surendiran, A., Sandhiya, S., Pradhan, S.C., and Adithan, C. (2009) Novel applications of nanotechnology in medicine. Indian J. Med. Res., 130 (6), 689-701.
9. Youns, M., Hoheisel, J.D., and Efferth, T. (2011) Therapeutic and diagnostic applications of nanoparticles. Curr. Drug Targets, 12 (3), 357-365.
10. Medina-Sánchez, M., Miserere, S., and Merkoçi, A. (2012) Nanomaterials and lab-on-a-chip technologies. Lab Chip, 12 (11), 1932-1943.
11. Lim, Y.C., Kouzani, A.Z., and Duan, W. (2010) Aptasensors: a review. J. Biomed. Nanotechnol., 6 (2), 93-105.
12. Hong, P., Li, W., and Li, J. (2012) Applications of aptasensors in clinical diagnostics. Sensors, 12, 1181-1193.
13. Hahn, M.A., Singh, A.K., Sharma, P., Brown, S.C., and Moudgil, B.M. (2011) Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives. Anal. Bioanal. Chem., 399, 3-27.
14. Kim, K.M., Kang, J.H., Vinu, A., Choy, J.H., and Oh, J.M. (2013) Inorganic nanomedicines and their labeling for biological imaging. Curr. Top. Med. Chem., 13 (4), 488-503.
15. Anderson, C.J., Bulte, J.W.M., Chen, K., Chen, X., Khaw, B.-A., Shokeen, M., Wooley, K.L., and VanBrocklin, H.F. (2010) Design of targeted cardiovascular molecular imaging probes. J. Nucl. Med., 51 (01), 3S-17S.
16. Jennings, L.E. and Long, N.J. (2009) 'Two is better than one'-probes for dual-modality molecular imaging. Chem. Commun., 24, 3511-3524. doi: 10.1039/b821903f
17. Tran, T.D., Caruthers, S.D., Hughes, M., Marsh, J.N., Cyrus, T., Winter, P.M., Neubauer, A.M., Wickline, S.A., and Lanza, G.M. (2007) Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int. J. Nanomed., 2 (4), 515-526.
18. Nahrendorf, M., Zhang, H., Hembrador, S., Panizzi, P., Sosnovik, D.E., Aikawa, E., Libby, P., Swirski, F.K., and Weissleder, R. (2008) Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation, 117 (3), 379-387.
19. 18F Labeled nanoparticles for in vivo PET-CT imaging. Bioconjug. Chem., 20 (2), 397-401.
20. Hwang, D.W., Ko, H.Y., Kim, S.-K., Kim, D., Lee, D.S., and Kim, S. (2009) Development of a quadruple imaging modality by using nanoparticles. Chem. Eur. J., 15, 9387-9393.
21. Cabane, E., Zhang, X., Langowska, K., Palivan, C.G., and Meier, W. (2012) Stimuli-responsive polymers and their applications in nanomedicine. Biointer-phases, 7 (9), 1-27.
22. Wujcik, E.K. and Monty, C.N. (2013) Nanotechnology for implantable sensors: carbon nanotubes and graphene in medicine. WIREs Nanomed. Nanobiotechnol., 5, 233-249. doi: 10.1002/wnan.1213
23. Kiparissides, C. and Kammona, O. (2013) Nanoscale carriers for targeted delivery of drugs and therapeutic biomolecules. Can. J. Chem. Eng., 91, 638-651.
24. Juliano, R., Poste, G., and Tomlinson, E. (2013) Perspective from the founding editors. Adv. Drug. Delivery Rev., 65, 3-4.
25. Kamaly, N., Xiao, Z., Valencia, P.M., Radovic-Moreno, A.F., and Farokhzad, O.C. (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem. Soc. Rev., 41, 2971-3010. doi: 10.1039/c2cs15344k
26. Singh, S. (2010) Nanomedicine-nanoscale drugs and delivery systems. J. Nanosci. Nanotechnol., 10 (12), 7906-7918.
27. Petkar, K.C., Chavhan, S.S., Agatonovik-Kustrin, S., and Sawant, K.K. (2011) Nanostructured materials in drug and gene delivery: a review of the state of the art. Crit. Rev. Ther. Drug Carrier Syst., 28 (2), 101-164.
28. Adair, J.H., Parette, M.P., Altıinoglu, E.I., and Kester, M. (2010) Nanoparticulate alternatives for drug delivery. ACS Nano, 4 (9), 4967-4970.
29. Li, J., Wang, Y., Zhu, Y., and Oupický, D. (2013) Recent advances in delivery of drug-nucleic acid combinations for cancer treatment. J. Control. Release, 712 (2), 589-600.
30. Perche, F. and Torchilin, V.P. (2013) Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting. J. Drug Delivery, 2013, Article ID: 705265, 32 p.
31. Koshkaryev, A., Sawant, R., Deshpande, M., and Torchilin, V. (2013) Immunoconjugates and long circulating systems: origins, current state of the art and future directions. Adv. Drug Delivery Rev., 65, 24-35.
32. Allen, T.M. and Cullis, P.R. (2013) Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug. Delivery Rev., 65, 36-48.
33. Lee, S.C., Kwon, K., and Park, K. (2013) Hydrogels for delivery of bioactive agents: a historical perspective. Adv. Drug Delivery Rev., 65, 17-20.
34. Shi, J., Xiao, Z., Kamaly, N., and Farokhzad, O.C. (2011) Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc. Chem. Res., 44 (10), 1123-1134.
35. Lehner, R., Wang, X., Marsch, S., and Hunziker, P. (2013) Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application. Nanomed. Nanotechnol., 9 (6), 742-757.
36. Decuzzi, P., Pasqualini, R., Arap, W., and Ferrari, M. (2009) Intravascular delivery of particulate systems: does geometry really matter? Pharm. Res., 26 (1), 235-243.
37. Tao, L., Hu, W., Liu, Y., Huang, G., Sumer, B.D., and Gao, J. (2011) Shape-specific polymeric nanomedicine: emerging opportunities and challenges. Exp. Biol. Med., 236, 20-29.
38. Caldorera-Moore, M., Guimard, N., Shi, L., and Roy, K. (2010) Designer nanoparticles: incorporating size, shape, and triggered release into nanoscale drug carriers. Expert Opin. Drug Delivery, 7 (4), 479-495.
39. Yoo, J.-W., Doshi, N., and Mitragotri, S. (2011) Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv. Drug Delivery Rev., 63, 1247-1256.
40. Wang, J., Byrne, J.D., Napier, M.E., and DeSimone, J.M. (2011) More effective nanomedicines through particle design. Small, 7 (14), 1919-1931.
41. Luk, B.T., Fang, R.H., and Zhang, L. (2012) Lipid- and polymer-based nanostructures for cancer theranostics. Theranostics, 2 (12), 1117-1126.
42. Diou, O., Tsapis, N., and Fattal, E. (2012) Targeted nanotheranostics for personalized cancer therapy. Expert Opin. Drug Delivery, 9 (12), 1475-1487.
43. Fernandez-Fernandez, A., Manchanda, R., and McGoron, A.J. (2011) Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl. Biochem. Biotechnol., 165, 1628-1651.
44. Huynh, E. and Zheng, G. (2013) Engineering multifunctional nanoparticles: all-in-one versus one-for-all. Wiley Inter-discip. Rev. Nanomed. Nanobiotechnol., 5 (3), 250-265.
45. Bao, G., Mitragotri, S., and Tong, S. (2013) Multifunctional nanoparticles for drug delivery and molecular imaging. Annu. Rev. Biomed. Eng., 15, 253-282.
46. Jokerst, J.V. and Gambhir, S.S. (2011) Molecular imaging with theranostic nanoparticles. Acc. Chem. Res., 44 (10), 1050-1060.
47. Chen, Y. and Liu, L. (2012) Modern methods for delivery of drugs across the blood-brain barrier. Adv. Drug Delivery Rev., 64, 640-665.
48. Tosi, G., Bortot, B., Ruozi, B., Dolcetta, D., Vandelli, M.A., Forni, F., and Severini, G.M. (2013) Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. Curr. Med. Chem., 20, 2212-2225.
49. Kammona, O. and Kiparissides, C. (2012) Recent advances in nanocarrier-based mucosal delivery of biomolecules. J. Control. Release, 161, 781-794.
50. Bernkop-Schnürch, A. (2013) Nanocarrier systems for oral drug delivery: do we really need them? Eur. J. Pharm. Sci., 49 (2), 272-277.
51. Mansour, H.M., Rhee, Y.-S., and Wu, X. (2009) Nanomedicine in pulmonary delivery. Int. J. Nanomed., 4, 299-319.
52. Shakya, P., Madhav, N.V.S., Shakya, A.K., and Singh, K. (2011) Palatal mucosa as a route for systemic drug delivery: a review. J. Control. Release, 151, 2-9.
53. Antosova, Z., Mackova, M., Kral, V., and Macek, T. (2009) Therapeutic application of peptides and proteins: parenteral forever? Trends Biotechnol., 27 (11), 628-635.
54. Kompella, U.B., Amrite, A.C., Ravi, R.P., and Durazo, S.A. (2013) Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog. Retin. Eye Res., 36, 127-198.
55. Neubert, R.H.H. (2011) Potentials of new nanocarriers for dermal and transdermal drug delivery. Eur. J. Pharm. Biopharm., 77, 1-2.
56. Ndesendo, V.M.K., Pillay, V., Choonara, Y.E., Buchmann, E., Bayever, D.N., and Meyer, L.C.R. (2008) A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. AAPS Pharm. Sci. Technol., 9 (2), 505-520.
57. Engel, E., Michiardi, A., Navarro, M., Lacroix, D., and Planell, J.A. (2007) Nanotechnology in regenerative medicine: the materials side. Trends Biotechnol., 26 (1), 39-47.
58. Wan, A.C.A. and Ying, J.Y. (2010) Nano-materials for in situ cell delivery and tissue regeneration. Adv. Drug Delivery Rev., 62, 731-740.
59. Prescott, C. (2010) Regenerative nanomedicines: an emerging investment prospective? J. R. Soc. Interface, 7, S783-S787.
60. Verma, S., Domb, A.J., and Kumar, N. (2011) Nanomaterials for regenerative medicine. Nanomedicine, 6 (1), 157-181.
61. Parks, J., Kath, M., Gabrick, K., and Ver Halen, J.P. (2012) Nanotechnology applications in plastic and reconstructive surgery. Plast. Surg. Nurs., 32 (4), 156-164.
62. Saracino, G.A.A., Cigognini, D., Silva, D., Caprini, A., and Gelain, F. (2013) Nanomaterials design and tests for neural tissue engineering. Chem. Soc. Rev., 42, 225-262.
63. Ahmed, M., Yildirimer, L., Khademhosseini, A., and Seifalian, A.M. (2012) Nanostructured materials for cardiovascular tissue engineering. J. Nanosci. Nanotechnol., 12, 4775-4785.
64. Kim, H.N., Jiao, A., Hwang, N.S., Kim, M.S., Kang, D.H., Kim, D.-H., and Suh, K.-Y. (2013) Nanotopography-guided tissue engineering and regenerative medicine. Adv. Drug Delivery Rev., 65, 536-558.
65. La Francesca, S. (2012) Nanotechnology and stem cell therapy for cardiovascular diseases: potential applications. Methodist Debakey Cardiovasc. J., 8 (1), 28-35.
66. Kubinová, Š. and Syková, E. (2010) Nanotechnologies in regenerative medicine. Minimal. Invasiv. Ther., 19, 144-156.
67. Khang, D., Carpenter, J., Chun, Y.W., Pareta, R., and Webster, T.J. (2010) Nanotechnology for regenerative medicine. Biomed. Microdevices, 12, 575-587.
68. Yang, Y. and Leong, K.W. (2010) Nanoscale surfacing for regenerative medicine. WIREs Nanomed. Nanobiotechnol., 2, 478-495.
69. Khadka, D.B. and Haynie, D.T. (2012) Protein- and peptide-based electro-spun nanofibers in medical biomaterials. Nanomed. Nanotechnol., 8, 1242-1262.
70. Sridhar, R., Sundarrajan, S., Venugopal, J.R., Ravichandran, R., and Ramakrishna, S. (2013) Electrospun inorganic and polymer composite nanofibers for biomedical applications. J. Biomater. Sci. Polym. Ed., 24 (4), 365-385.
71. Hong, J.K. and Madihally, S.V. (2011) Next generation of electrosprayed fibers for tissue regeneration. Tissue Eng. Part B, 17 (2), 125-142.
72. Luo, Z. and Zhang, S. (2012) Designer nanomaterials using chiral self-assembling peptide systems and their emerging benefit for society. Chem. Soc. Rev., 41 (13), 4736-4754.
73. Xu, C., Mu, L., Roes, I., Miranda-Nieves, D., Nahrendorf, M., Ankrum, J.A., Zhao, W., and Karp, J.M. (2011) Nanoparticle-based monitoring of cell therapy. Nanotechnology, 22, 494001, (17 pp).
74. Giraud, M.-N., Guex, A.G., and Tevaearai, H.T. (2012) Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies. Cardiol. Res. Practice, 2012, Article ID 971614, 10 pp, doi: 10.1155/2012/971614.
75. Koutsopoulos, S. (2012) Molecular fabrications of smart nanobiomaterials and applications in personalized medicine. Adv. Drug Delivery Rev., 64, 1459-1476.
76. Vizirianakis, I.S. and Fatouros, D.G. (2012) Personalized nanomedicine: paving the way to the practical clinical utility of genomics and nanotechnology advancements. Adv. Drug Delivery Rev., 64, 1359-1362.
77. Mura, S. and Couvreur, P. (2012) Nanotheranostics for personalized medicine. Adv. Drug Delivery Rev., 64, 1394-1416.
78. Singhal, S., Nie, S., and Wang, M.D. (2010) Nanotechnology applications in surgical oncology. Annu. Rev. Med., 61, 359-373.
79. Khang, D., Carpenter, J., Wook Chun, Y., Pareta, R., and Webster, T.J. (2010) Nanotechnology for regenerative medicine. Biomed. Microdevices, 12, 575-587.
80. Zarbin, M.A., Montemagno, C., Leary, J.F., and Ritch, R. (2010) Nanotechnology in ophthalmology. Can. J. Opthalmol., 45 (5), 457-476.
81. Loizidou, M. and Seifalian, A.M. (2010) Nanotechnology and its applications in surgery. Br. J. Surg., 97, 463-465.
82. Ozak, S.T. and Ozkan, P. (2013) Nanotechnology and dentistry. Eur. J. Dent., 7, 145-151.
83. Zakri, R.H., Zakri, R., Zakri, S., and Hassan, K.U. (2011) Nanotechnology in surgery: tiny solutions for titanic problems. Ann. Pak. Inst. Med. Sci., 7 (1), 37-41.
84. Andrews, R.J. (2009) Nanotechnology and neurosurgery. J. Nanosci. Nanotechnol., 9 (8), 5008-5013.